MenopauseONTIME-CHOCNCT03949803
Eating Chocolate at the Right Time Benefits the Circadiam Sytem and Metabolic Efficiency.
A study testing Chocolate 100gr in people with Menopause, run by Universidad de Murcia.
Trial summary
The purpose of this investigation is to test the hypothesis that in humans, eating a relatively big amount of chocolate at the wrong time (bedtime) may disrupt our circadian system (change the circadian phase), while taking this same amount of chocolate in the morning (wake up condition) may synchronize it. Read more about this study
- Who is it for?
- Ages 45 to 65 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Menopause
- What is being tested?
- Chocolate 100gr
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 19 participants
- Where
- No sites listed yet
- Study dates
- 1 Nov 2016to 20 Apr 2017
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 65 years
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Healthy women
- Age: between 45 and 65 year of age
- Caucasian
- Menopause
Who cannot join
- Pre-menopause women
- Endocrine (Diabetes mellitus or others), renal, hepatic, cancer or psychiatric disorders
- Receiving any pharmacologic treatment other than oral contraceptives
- Bulimia diagnosis, prone to binge eating
- Pregnancy
About this study
Official title: Effect of the Timing of Chocolate Intake on Body Fat Distribution, Substrate Oxidation, and Microbiota. Randomized, Crossover Study
The purpose of this investigation is to test the hypothesis that in humans, eating a relatively big amount of chocolate at the wrong time (bedtime) may disrupt our circadian system (change the circadian phase), while taking this same amount of chocolate in the morning (wake up condition) may synchronize it. Other related factors may be also affected such as total body weight and body fat, dietary habits (total energy intake and macronutrient distribution), the timing of food intake and of sleep, daily rhythms of TAP, microflora composition and postprandial glycemia.
Read the detailed description
Recent studies suggest that not only "what" the people eat, but also "when" the people eat may have a significant role in obesity treatment and in the regulation of the circadian system. Thus, the hypothesis of this study is eating a relatively big amount of chocolate at the wrong time, bedtime may affect:
- Metabolism: resting energy expenditure, corrected resting energy respiratory quotient (RQ)
- Glucose metabolism
- Total weight loss
- Food intake, total energy intake, and type of food
- Microflora (feces)
- Mood
- Disrupt our circadian system 7a) Changes in Temperature, Actimetry, and Position 7b) Electrocardiogram (ECG) 7c) Melatonin (two points) cortisol rhythm (three points) While having this same amount of chocolate in the morning (wake up condition) may synchronize it.
Other related factors may be also affected such as total body weight and body fat, dietary habits (total energy intake and macronutrient distribution), the timing of food intake and of sleep, daily rhythms of TAP, microflora composition and postprandial glycemia.
19 women (postmenopausal) following the habitual dietary habits of participants (ad libitum) will have 30% of the habitual total daily calories in chocolate of participants (Nestle, "chocolate with milk") during two consecutive weeks each under three conditions: eating chocolate within 1 hour of habitual wake-time, eating chocolate within 1 hours of habitual bedtime, or eating no chocolate. No other chocolate (i.e., none at all in control and in the washout weeks).
The protocol will be a randomized, cross-over design, with a 1-week washout between each condition.
During the 14 days in each condition, the participants will record sleep and activity schedules by dairy, food intake and food timing by phone application, daily rhythms of wrist temperature, activity and position (TAP).
- Conditions
- Menopause
- Being tested
- Chocolate 100gr
- Keywords
- Chocolate, Timing, Menopause, Calorimetry
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Chocolate 100grBehavioural
Evening/Night Chocolate:
Eating 100gr of milk chocolate within 1 hours of habitual bedtime
Control Chocolate:
Eating no milk chocolate or other chocolate
Chocolate Morning:
Eating chocolate within one hour of habitual waketime.
| Study group | Role | What they receive |
|---|---|---|
| Morning Chocolate, then Evening/Night Chocolate and Control Chocolate | Experimental | First condition is eating 100gr chocolate within one hour of habitual waketime. Second condition is eating 100gr of milk chocolate within 1 hours of habitual bedtime.
Third condition is eating no milk chocolate or other chocolate. Receives: Behavioral: Chocolate 100gr |
| Morning Chocolate, then Control Chocolate and Evening/Night Chocolate | Experimental | First condition is eating 100gr chocolate within one hour of habitual waketime. Second condition is eating no milk chocolate or other chocolate. Third condition is eating 100gr of milk chocolate within 1 hours of habitual bedtime. Receives: Behavioral: Chocolate 100gr |
| Evening/Night Chocolate, then Morning Chocolate and Control Chocolate | Experimental | First condition is eating 100gr of milk chocolate within 1 hours of habitual bedtime.
Second condition is eating 100gr chocolate within one hour of habitual waketime.
Third condition is eating no milk chocolate or other chocolate. Receives: Behavioral: Chocolate 100gr |
| Evening/Night Chocolate, then Control Chocolate and Morning Chocolate | Experimental | First condition is eating 100gr of milk chocolate within 1 hours of habitual bedtime.
Second condition is eating no milk chocolate or other chocolate. Third condition is eating 100gr chocolate within one hour of habitual waketime. Receives: Behavioral: Chocolate 100gr |
| Control Chocolate, then Morning Chocolate and Evening/Night Chocolate | Experimental | First condition is eating no milk chocolate or other chocolate. Second condition is eating 100gr chocolate within one hour of habitual waketime.
Third condition is eating 100gr of milk chocolate within 1 hours of habitual bedtime. Receives: Behavioral: Chocolate 100gr |
| Control Chocolate, then Evening/Night Chocolate and Morning Chocolate | Experimental | First condition is eating no milk chocolate or other chocolate. Second condition is eating 100gr of milk chocolate within 1 hours of habitual bedtime.
Third condition is eating 100gr chocolate within one hour of habitual waketime. Receives: Behavioral: Chocolate 100gr |
What is being measured
The primary outcome is the main question the study is designed to answer.
Resting Energy Expenditure (Indirect Calorimetry)
The investigators will measure by indirect calorimetry the resting energy expenditure after each condition (no chocolate, Morning Chocolate, Night Chocolate) Changes in Resting Energy Expenditure (Indirect Calorimetry) were determined by changes in resting energy expenditure occurred in the participants between baseline and after 2 weeks in each of the three different experimental conditions. Oxygen (O2) consumption (mL/min) and carbon dioxide (CO2) production (mL/min) were measured. The Respiratory Quotient (RQ) was calculated out of O2 consumption (mL/min) and CO2 production (mL/min). Energy expenditure values (kcal/day) were calculated according to the Weir equation: Metabolic rate (kcal per day) = 1440 (3.9 VO2 + 1.1 VCO2)*
Measured: Baseline and after 2 weeks in each condition
Total Body Weight
The investigators will measure total body weight after each condition (no chocolate, Morning Chocolate, Night Chocolate)
Measured: Baseline and after 2 weeks in each condition
Secondary outcomes (7)
Fragmentation of Wrist Temperature (WT) Daily Rhythm
The investigators will measure the fragmentation parameter derived from wrist temperature after each condition (no chocolate, Morning Chocolate, Night Chocolate). Intradaily variability (IV) characterizes the rhythm fragmentation.
Changes in daily rhythm of wrist temperature fragmentation were measured by changes in the fragmentation parameter derived from wrist temperature along the two weeks of intervention in each of the three conditions. The participants wore a wristwatch during the last 7 days of each condition on the non-dominant wrist to record body temperature and activity. Wrist temperature parameters were measured to represent the wrist body temperature pattern, which provides an objectively measure of sleep and siesta (together with activity rhythm).
A low fragmentation involves a low intraday rhythmicity of the circadian rhythm.
Its values oscillated between 0, when the wave was perfectly sinusoidal, and 2, when the wave was as Gaussian noise.
Measured: Baseline and after 2 weeks in each condition
Regularity of Wrist Temperature (WT) Daily Rhythm
The investigators will measure the regularity parameter derived from wrist temperature after each condition (no chocolate, Morning Chocolate, Night Chocolate). RegularIty is measured as interdaily stability (IS), that means rhythm stability over different days; it varied between 0 for Gaussian noise to 1 for perfect stability, where the rhythm repeated itself exactly day after day.
Changes in daily rhythm of wrist temperature regularity were measured by changes in the regularity parameter derived from wrist temperature along the two weeks of intervention in each of the three conditions. A regular rhythm means recurring at uniform intervals. The participants wore a wristwatch during the last 7 days of each condition on the non-dominant wrist to record body temperature and activity. Wrist temperature parameters were measured to represent the wrist body temperature pattern, which provides an objectively measure of sleep and siesta (together with activity rhythm).
Measured: Baseline and after 2 weeks in each condition
Amplitude of Wrist Temperature (WT) Daily Rhythm
The investigators will measure the amplitude parameter derived from wrist temperature after each condition (no chocolate, Morning Chocolate, Night Chocolate). In the cosinor analysis to characterize the WT rhythm, we calculate amplitude (difference between the maximum [or minimum] value of the cosine function and mesor) Changes in daily rhythm of wrist temperature amplitude were measured by changes in the amplitude parameter derived from wrist temperature along the two weeks of intervention in each of the three conditions. The participants wore a wristwatch during the last 7 days of each condition on the non-dominant wrist to record body temperature and activity. Wrist temperature parameters were measured to represent the wrist body temperature pattern, which provides an objectively measure of sleep and siesta (together with activity rhythm).
A healthy circadian rhythm is considered as the one with high amplitude.
Measured: Baseline and after 2 weeks in each condition
Changes in Microbiota Diversity (Inverse Simpson Index)
Microbiota diversity changes were measured using Inverse Simpson Index, accounting for both species richness (number of species) and evenness (distribution of species). A higher Inverse Simpson Index indicates greater diversity because it reduces the impact of dominant species and gives more weight to rarer species. Unlike the regular Simpson Index (which decreases as diversity increases), the inverse form is more intuitive: higher values mean a more diverse microbiota. This index is widely used in microbiome studies to compare microbial diversity across different samples, such as in health versus disease states.
Measured: Baseline and after 2 weeks in each condition
Concentration of Total Short-chain Fatty Acids (SCFAs)
Short-chain fatty acids (SCFAs) in fecal samples were analyzed using gas-liquid chromatography (GLC) with a GC-FID system. Samples were mixed with NaOH, lyophilized, and homogenized with formic acid, methanol, and an internal standard (2-ethyl butyric acid). After ultrasonic treatment and centrifugation, the supernatant was filtered and injected into an Agilent 7890A GC system equipped with a Nukol capillary column. Helium was used as the carrier gas, and the FID temperature was set at 220°C. SCFAs were identified by comparing retention times with authentic standards, and quantification was performed using calibration curves with a high correlation (R² = 0.99). Total average values of SCFA (acetate, propionate, other minorities) in each condition were calculated.
Measured: After 2 weeks in each condition
Energy Intake
The investigators will measure changes in total energy intake measured as kilocalories between baseline and after 2 weeks in each condition (no chocolate, Morning Chocolate, Night Chocolate) At baseline and during the 2 weeks of each condition, time-stamped photographs were captured with a cell phone app. Total energy intake during the 14 days of each condition was analyzed with the nutritional evaluation software (Grunumur 2.0 8).
Measured: Baseline and after 2 weeks in each condition
Macronutrient Composition
The investigators will measure macronutrient composition measured as and grams per day between baseline and after 2 weeks in each condition (no chocolate, Morning Chocolate, Night Chocolate). At baseline and during the 2 weeks of each condition, time-stamped photographs were captured with a cell phone app. Macronutrient composition during the 14 days of each condition was analyzed with the nutritional evaluation software (Grunumur 2.0 8).
Measured: Baseline and after 2 weeks in each condition
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 May 2019
- Study start1 Nov 2016
- Primary completion15 Jan 2017
- Study completion20 Apr 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for MenopauseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 19 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universidad de Murcia
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, PROF. MARTA GARAULET AZA, Universidad de Murcia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03949803
- Sponsor's protocol ID
- 2017ES00004
- Acronym
- ONTIME-CHOC
- Status last verified
- Mar 2025
- First submitted
- 8 Feb 2018
- Last updated
- 15 Apr 2025
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Hernandez-Gonzalez T, Gonzalez-Barrio R, Escobar C, Madrid JA, Periago MJ, Collado MC, Scheer FAJL, Garaulet M. Timing of chocolate intake affects hunger, substrate oxidation, and microbiota: A randomized controlled trial. FASEB J. 2021 Jul;35(7):e21649. doi: 10.1096/fj.202002770RR.
PubMed 34164846
Study at a glance
From the registry record, last updated by the sponsor on 15 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of the Timing of Chocolate Intake on Body Fat Distribution, Substrate Oxidation, and Microbiota. Randomized, Crossover Study
- ClinicalTrials.gov ID
- NCT03949803
- Acronym / sponsor ID
- ONTIME-CHOC / 2017ES00004
- Conditions
- Menopause
- Keywords
- Chocolate, Timing, Menopause, Calorimetry
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 19 participants (actual)
- Lead sponsor
- Universidad de MurciaUniversity, hospital or other
- Study start
- 1 Nov 2016 (actual)
- Primary completion
- 15 Jan 2017 (actual)
- Study completion
- 20 Apr 2017 (actual)
- First posted
- 14 May 2019 (actual)
- Results
- Posted 15 Apr 2025
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this investigation is to test the hypothesis that in humans, eating a relatively big amount of chocolate at the wrong time (bedtime) may disrupt our circadian system (change the circadian phase), while taking this same amount of chocolate in the morning (wake up condition) may synchronize it. Other related factors may be also affected such as total body weight and body fat, dietary habits (total energy intake and macronutrient distribution), the timing of food intake and of sleep, daily rhythms of TAP, microflora composition and postprandial glycemia.
Detailed description
Recent studies suggest that not only "what" the people eat, but also "when" the people eat may have a significant role in obesity treatment and in the regulation of the circadian system. Thus, the hypothesis of this study is eating a relatively big amount of chocolate at the wrong time, bedtime may affect:
- Metabolism: resting energy expenditure, corrected resting energy respiratory quotient (RQ)
- Glucose metabolism
- Total weight loss
- Food intake, total energy intake, and type of food
- Microflora (feces)
- Mood
- Disrupt our circadian system 7a) Changes in Temperature, Actimetry, and Position 7b) Electrocardiogram (ECG) 7c) Melatonin (two points) cortisol rhythm (three points) While having this same amount of chocolate in the morning (wake up condition) may synchronize it.
Other related factors may be also affected such as total body weight and body fat, dietary habits (total energy intake and macronutrient distribution), the timing of food intake and of sleep, daily rhythms of TAP, microflora composition and postprandial glycemia.
19 women (postmenopausal) following the habitual dietary habits of participants (ad libitum) will have 30% of the habitual total daily calories in chocolate of participants (Nestle, "chocolate with milk") during two consecutive weeks each under three conditions: eating chocolate within 1 hour of habitual wake-time, eating chocolate within 1 hours of habitual bedtime, or eating no chocolate. No other chocolate (i.e., none at all in control and in the washout weeks).
The protocol will be a randomized, cross-over design, with a 1-week washout between each condition.
During the 14 days in each condition, the participants will record sleep and activity schedules by dairy, food intake and food timing by phone application, daily rhythms of wrist temperature, activity and position (TAP).
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 6
| Arm | Type | Receives |
|---|---|---|
| Morning Chocolate, then Evening/Night Chocolate and Control Chocolate | Experimental | Behavioral: Chocolate 100grFirst condition is eating 100gr chocolate within one hour of habitual waketime. Second condition is eating 100gr of milk chocolate within 1 hours of habitual bedtime. Third condition is eating no milk chocolate or other chocolate. |
| Morning Chocolate, then Control Chocolate and Evening/Night Chocolate | Experimental | Behavioral: Chocolate 100grFirst condition is eating 100gr chocolate within one hour of habitual waketime. Second condition is eating no milk chocolate or other chocolate. Third condition is eating 100gr of milk chocolate within 1 hours of habitual bedtime. |
| Evening/Night Chocolate, then Morning Chocolate and Control Chocolate | Experimental | Behavioral: Chocolate 100grFirst condition is eating 100gr of milk chocolate within 1 hours of habitual bedtime. Second condition is eating 100gr chocolate within one hour of habitual waketime. Third condition is eating no milk chocolate or other chocolate. |
| Evening/Night Chocolate, then Control Chocolate and Morning Chocolate | Experimental | Behavioral: Chocolate 100grFirst condition is eating 100gr of milk chocolate within 1 hours of habitual bedtime. Second condition is eating no milk chocolate or other chocolate. Third condition is eating 100gr chocolate within one hour of habitual waketime. |
| Control Chocolate, then Morning Chocolate and Evening/Night Chocolate | Experimental | Behavioral: Chocolate 100grFirst condition is eating no milk chocolate or other chocolate. Second condition is eating 100gr chocolate within one hour of habitual waketime. Third condition is eating 100gr of milk chocolate within 1 hours of habitual bedtime. |
| Control Chocolate, then Evening/Night Chocolate and Morning Chocolate | Experimental | Behavioral: Chocolate 100grFirst condition is eating no milk chocolate or other chocolate. Second condition is eating 100gr of milk chocolate within 1 hours of habitual bedtime. Third condition is eating 100gr chocolate within one hour of habitual waketime. |
Who may qualify
- Ages
- 45 to 65 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Healthy women
- Age: between 45 and 65 year of age
- Caucasian
- Menopause
Key exclusion criteria (5 listed)
- Pre-menopause women
- Endocrine (Diabetes mellitus or others), renal, hepatic, cancer or psychiatric disorders
- Receiving any pharmacologic treatment other than oral contraceptives
- Bulimia diagnosis, prone to binge eating
- Pregnancy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Chocolate 100grEvening/Night Chocolate: Eating 100gr of milk chocolate within 1 hours of habitual bedtime Control Chocolate: Eating no milk chocolate or other chocolate Chocolate Morning: Eating chocolate within one hour of habitual waketime. | Behavioural | Control Chocolate, then Evening/Night Chocolate and Morning Chocolate, Control Chocolate, then Morning Chocolate and Evening/Night Chocolate, Evening/Night Chocolate, then Control Chocolate and Morning Chocolate, Evening/Night Chocolate, then Morning Chocolate and Control Chocolate, Morning Chocolate, then Control Chocolate and Evening/Night Chocolate, Morning Chocolate, then Evening/Night Chocolate and Control Chocolate |
Primary outcome
Resting Energy Expenditure (Indirect Calorimetry)
Time frame: Baseline and after 2 weeks in each condition
The investigators will measure by indirect calorimetry the resting energy expenditure after each condition (no chocolate, Morning Chocolate, Night Chocolate) Changes in Resting Energy Expenditure (Indirect Calorimetry) were determined by changes in resting energy expenditure occurred in the participants between baseline and after 2 weeks in each of the three different experimental conditions. Oxygen (O2) consumption (mL/min) and carbon dioxide (CO2) production (mL/min) were measured. The Respiratory Quotient (RQ) was calculated out of O2 consumption (mL/min) and CO2 production (mL/min). Energy expenditure values (kcal/day) were calculated according to the Weir equation: Metabolic rate (kcal per day) = 1440 (3.9 VO2 + 1.1 VCO2)*
Total Body Weight
Time frame: Baseline and after 2 weeks in each condition
The investigators will measure total body weight after each condition (no chocolate, Morning Chocolate, Night Chocolate)
7 secondary outcomes
Fragmentation of Wrist Temperature (WT) Daily Rhythm
Time frame: Baseline and after 2 weeks in each condition
Regularity of Wrist Temperature (WT) Daily Rhythm
Time frame: Baseline and after 2 weeks in each condition
Amplitude of Wrist Temperature (WT) Daily Rhythm
Time frame: Baseline and after 2 weeks in each condition
Changes in Microbiota Diversity (Inverse Simpson Index)
Time frame: Baseline and after 2 weeks in each condition
Concentration of Total Short-chain Fatty Acids (SCFAs)
Time frame: After 2 weeks in each condition
Energy Intake
Time frame: Baseline and after 2 weeks in each condition
Macronutrient Composition
Time frame: Baseline and after 2 weeks in each condition
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Apr 2025.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Derived from this study: PubMed 34164846Hernandez-Gonzalez T, Gonzalez-Barrio R, Escobar C, Madrid JA, Periago MJ, Collado MC, Scheer FAJL, Garaulet M. Timing of chocolate intake affects hunger, substrate oxidation, and microbiota: A randomized controlled trial. FASEB J. 2021 Jul;35(7):e21649. doi: 10.1096/fj.202002770RR.
- Individual participant dataSharing planned: Undecided
Related trials for Menopause
Recruiting
Hop Extract Versus Soy Isoflavone Extract for Menopausal Symptoms (HOPES)
Menopause, Perimenopause
Not yet recruiting
The Role of Diet Quality in Sleep Among Women in Postmenopause
Post Menopausal Women
Active, not recruitingPhase 3
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
Infertility (IVF Patients)
Not yet recruiting
Effect of Hormone Replacement Therapy on Physiotherapy Outcomes in Postmenopausal Women With Frozen Shoulder
Frozen Shoulder, Adhesive Capsulitis
RecruitingObservational study
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Chocolate 100gr in people with Menopause, run by Universidad de Murcia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 15 Apr 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Resting Energy Expenditure (Indirect Calorimetry) (time frame: Baseline and after 2 weeks in each condition). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03949803, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Apr 2025.